urea has been researched along with rifampin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (53.85) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Marchin, GL; Müller, UR | 1 |
| Konze-Thomas, B; Rüger, W | 1 |
| Belova, IP; Gol'dberg, LE; Muraveĭskaia, VS; Stepanova, ES; Vertogradova, TP | 1 |
| Josse, RG | 1 |
| Ishihama, A | 1 |
| Flynn, CT; Hope, E; Rainford, DJ | 1 |
| Radenbach, KL | 1 |
| Jones, WL; McKittrick, L; Stewart, PS; Sutton, MP | 1 |
| Borlak, J; Chougule, A; Singh, PK | 1 |
| Martin, SJ; Sabina, EP | 1 |
| Abe, M; Inoue, A; Katsuda, T; Kawamata, M; Ochiya, T; Yamaguchi, T | 1 |
| Li, X; Meade, J; Ruiz-Soto, R; Shelton, MJ; Wang, J | 1 |
1 trial(s) available for urea and rifampin
| Article | Year |
|---|---|
Results of clinical studies with capreomycin, ethambutol and rifampicin in the Heckeshorn Hospital, Berlin.
Topics: Aged; Aminosalicylic Acids; Anti-Bacterial Agents; Berlin; Clinical Trials as Topic; Cycloserine; Drug Resistance, Microbial; Ethambutol; Humans; Hypocalcemia; Hypokalemia; Kidney Diseases; Middle Aged; Rifampin; Tetracycline; Tuberculosis, Pulmonary; Urea; Vision Disorders | 1969 |
12 other study(ies) available for urea and rifampin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Temporal appearance of bacteriophage T4-modified valyl tRNA synthetase in Escherichia coli.
Topics: Amino Acyl-tRNA Synthetases; Aminohydrolases; Cell-Free System; Centrifugation, Density Gradient; Chloramphenicol; Coliphages; DNA Viruses; Drug Stability; Escherichia coli; Genes; Oxidoreductases; Phosphotransferases; Rifampin; Thymidine; Thymine Nucleotides; Tritium; Urea; Valine; Viral Proteins | 1975 |
Functional hybrid enzymes reconstituted from Escherichia coli and Serratia marcescens RNA polymerase subunits.
Topics: Binding Sites; Coliphages; DNA-Directed RNA Polymerases; Escherichia coli; Galactosidases; Macromolecular Substances; Protein Binding; Protein Biosynthesis; Rifampin; Serratia marcescens; Transcription, Genetic; Urea | 1976 |
[The toxicity and pharmacologic properties of rifampicin].
Topics: Administration, Oral; Animals; Blood Cell Count; Blood Pressure; Body Weight; Cats; Depression, Chemical; Digestive System; Dose-Response Relationship, Drug; Female; Heart; Injections, Intraperitoneal; Kidney; Lipids; Liver; Liver Glycogen; Lung; Male; Mice; Neuromuscular Junction; Organ Size; Rats; Respiration; Rifampin; Sex Factors; Thyroid Gland; Transaminases; Urea | 1974 |
Gram-positive septicaemia in rheumatoid arthritis.
Topics: Ampicillin; Arthritis, Rheumatoid; Fusidic Acid; Humans; Lincomycin; Male; Middle Aged; Penicillin Resistance; Potassium; Rifampin; Sepsis; Staphylococcal Infections; Urea | 1974 |
Subunits of ribonucleic acid polymerase in function and structure. I. Reversible dissociations of Escherichia coli ribonucleic acid polymerase.
Topics: Adenosine Triphosphate; Binding Sites; Carbon Isotopes; Chloromercuribenzoates; Chromatography, Gel; DNA; Electrophoresis, Disc; Escherichia coli; Macromolecular Substances; Models, Chemical; Molecular Weight; Peptides; Rifampin; RNA Nucleotidyltransferases; Templates, Genetic; Ultracentrifugation; Urea | 1972 |
Acute renal failure and rifampicin: danger of unsuspected intermittent dosage.
Topics: Acute Kidney Injury; Aged; Antibody Formation; Bilirubin; Biopsy; Diarrhea; Female; Humans; Kidney; Nausea; Rifampin; Urea | 1974 |
Chemical and antimicrobial treatments change the viscoelastic properties of bacterial biofilms.
Topics: Biofilms; Cations; Ciprofloxacin; Disinfectants; Elasticity; Glutaral; Materials Testing; Models, Theoretical; Pseudomonas aeruginosa; Rheology; Rifampin; Staphylococcus epidermidis; Urea; Viscosity | 2011 |
How useful are clinical liver function tests in in vitro human hepatotoxicity assays?
Topics: Acetaminophen; Alanine Transaminase; Albumins; Alkaline Phosphatase; Amiodarone; Aspartate Aminotransferases; Biological Assay; Chemical and Drug Induced Liver Injury; gamma-Glutamyltransferase; Hep G2 Cells; Hepatocytes; Humans; L-Lactate Dehydrogenase; Liver Function Tests; Petasites; Plant Extracts; Rifampin; Urea | 2014 |
Amelioration of anti-tuberculosis drug induced oxidative stress in kidneys by Spirulina fusiformis in a rat model.
Topics: Acute Kidney Injury; Animals; Antioxidants; Antitubercular Agents; Creatinine; Disease Models, Animal; Female; Humans; Isoniazid; Kidney; Lipid Peroxidation; Liver; Oxidative Stress; Protective Agents; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Rifampin; Silymarin; Spirulina; Urea; Uric Acid | 2016 |
Long-term maintenance of functional primary human hepatocytes using small molecules.
Topics: Amides; Cell Proliferation; Cells, Cultured; Cytochrome P-450 Enzyme System; Glycogen; Hepatocytes; Humans; Phenobarbital; Primary Cell Culture; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Rifampin; Urea | 2020 |
Effects of CYP3A Inhibition, CYP3A Induction, and Gastric Acid Reduction on the Pharmacokinetics of Ripretinib, a Switch Control KIT Tyrosine Kinase Inhibitor.
Topics: Adult; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Therapy, Combination; Gastric Acid; Humans; Imatinib Mesylate; Itraconazole; Naphthyridines; Pantoprazole; Protein Kinase Inhibitors; Proton Pump Inhibitors; Rifampin; Urea | 2022 |